Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALXN | GSK | ARGX | ||
| Company | Alexion Pharm Inc | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 181.04 | 33.13 | 623.20 | ||
| High | 182.67 | 33.87 | 634.40 | ||
| Low | 180.13 | 33.04 | 619.60 | ||
| Last | 182.50 | 33.60 | 623.82 | ||
| Change | +3.05 | +0.17 | -2.21 | ||
| % Change | +1.70% | +0.51% | -0.35% | ||
| Volume | 90,506,096 | 6,813,000 | 313,100 | ||
| 20-Day Average Volume | 8,395,359 | 4,260,765 | 292,415 | ||
| Previous Close | 179.45 | 33.43 | 626.03 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 183.19 | 34.28 | 616.52 | ||
| 20-Day Raw Stochastic | 44.63% | 17.26% | 51.80% | ||
| 20-Day Relative Strength | 55.14% | 40.00% | 58.63% | ||
| Weighted Alpha | +62.81 | -16.88 | +74.52 | ||
| Today's Opinion | 72% Buy | 100% Sell | 100% Buy | ||
| Previous Opinion | 72% Buy | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.87% since 07/13/21 | -1.03% since 12/13/24 | +2.74% since 12/13/24 | ||
| Low | 178.51 on 07/19/21 | 33.04 on 12/20/24 | 613.95 on 12/19/24 | ||
| High | 187.45 on 07/14/21 | 34.56 on 12/17/24 | 644.97 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +1.00% since 06/18/21 | +0.75% since 11/20/24 | +5.41% since 11/20/24 | ||
| Low | 178.51 on 07/19/21 | 33.04 on 12/20/24 | 582.07 on 11/21/24 | ||
| High | 187.45 on 07/14/21 | 36.28 on 12/09/24 | 644.97 on 12/17/24 | ||
| 3-Month | |||||
| %Chg | +9.58% since 04/20/21 | -17.65% since 09/20/24 | +17.04% since 09/20/24 | ||
| Low | 164.83 on 04/29/21 | 32.83 on 11/15/24 | 512.01 on 09/24/24 | ||
| High | 187.45 on 07/14/21 | 41.80 on 10/09/24 | 644.97 on 12/17/24 | ||
| 6-Month | |||||
| %Chg | +15.70% since 01/20/21 | -17.57% since 06/20/24 | +60.83% since 06/20/24 | ||
| Low | 146.97 on 03/04/21 | 32.83 on 11/15/24 | 387.04 on 06/21/24 | ||
| High | 187.45 on 07/14/21 | 44.67 on 08/27/24 | 644.97 on 12/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 40,335,968 | 69,637,680 | 37,658,764 | ||
| Shares Outstanding, K | 221,019 | 2,072,550 | 60,368 | ||
| Annual Sales | 6,069,900,000 | 37,725,000,000 | 1,268,590,000 | ||
| Annual Net Income | 603,400,000 | 6,129,940,000 | -295,050,000 | ||
| Last Quarter Sales | 1,636,500,000 | 10,420,410,000 | 588,880,000 | ||
| Last Quarter Net Income | 636,000,000 | -75,430,000 | 91,410,000 | ||
| 60-Month Beta | 1.25 | 0.64 | 0.59 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 3.52 on 04/30/21 | 1.27 on 10/30/24 | 1.39 on 10/31/24 | ||
| Latest Earnings Date | 07/29/21 | 01/29/25 | 10/31/24 | ||
| Most Recent Dividend | N/A | 0.382 on 11/15/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/15/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.07 | 8.06 | 0.00 | ||